메뉴 건너뛰기




Volumn 842, Issue 1, 2006, Pages 1-7

Retraction Notice to "Validation and application of a high-performance liquid chromatographic based assay for determination of the inosine 5′-monophosphate dehydrogenase activity in erythrocytes" [J. Chromatogr. B 842 (2006) 1-7] (DOI:10.1016/j.jchromb.2006.04.040);Validation and application of a high-performance liquid chromatographic-based assay for determination of the inosine 5′-monophosphate dehydrogenase activity in erythrocytes

Author keywords

Enzyme; HPLC; Inosine 5 monophosphate dehydrogenase; Leukaemia; Thiopurine

Indexed keywords

CELLS; DRUG PRODUCTS; ENZYME KINETICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PIGMENTS; TUMORS;

EID: 33748195481     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2008.02.001     Document Type: Erratum
Times cited : (6)

References (30)
  • 23
    • 33748162389 scopus 로고    scopus 로고
    • FDA Advisory Committee for Pharmaceutical since. Clinical pharmacology subcommittee, 23 (October 2002). Scientific and practical considerations in the use of pharmacogenetic tests to determine drug dosage and administration.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.